Concord Wealth Partners’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
MG
Concord Wealth Partners's EXEL Position: Q2 2022 in Review
Concord Wealth Partners sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 464 shares — an estimated $11K sold.
Concord Wealth Partners first reported a position in EXEL in Q2 2021 and held it in 4 quarters. The position peaked at $11K in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.
- Concord Wealth Partners reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
- Concord Wealth Partners sold 464 Exelixis shares in Q2 2022, an estimated $11K.
- Concord Wealth Partners first reported a position in Exelixis in Q2 2021 and held it in 4 quarters.
- Concord Wealth Partners's Exelixis position peaked at $11K in Q1 2022.
- 373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.
Based on Concord Wealth Partners's 13F filing for Q2 2022, filed 4 Aug 2022.